APYXApyx Medical Corp

Nasdaq apyxmedical.com


$ 1.03 $ 0.02 (1.92 %)    

Friday, 09-Aug-2024 15:59:50 EDT
QQQ $ 451.00 $ 0.97 (0.22 %)
DIA $ 393.81 $ -1.38 (-0.35 %)
SPY $ 533.05 $ 0.28 (0.05 %)
TLT $ 96.62 $ 0.35 (0.36 %)
GLD $ 228.41 $ 3.85 (1.71 %)
$ 1.06
$ 1.02 x 100
-- x --
-- - --
$ 0.97 - $ 5.00
28,845
na
36.72M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-31-2020 12-31-2019 10-K
20 11-15-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-14-2019 12-31-2018 10-K
24 11-02-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-13-2018 12-31-2017 10-K
28 11-03-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-10-2017 12-31-2016 10-K
32 10-27-2016 09-30-2016 10-Q
33 08-02-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 03-18-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apyx-medical-announces-peer-reviewed-clinical-publication-comparing-the-use-of-renuvion-to-a-competing-technology-following-liposuction-or-body-contouring-procedures

Demonstrates a statistically significant reduction in adverse events associated with the use of Renuvion following liposuction ...

 apyx-medical-q2-gaap-eps-019-beats-020-estimate-sales-1215m-beat-1175m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) ...

 apyx-medicals-new-renewing-lives-campaign-offers-free-renuvion-treatments-to-those-in-need

Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary heli...

 apyx-medical-q1-eps-022-misses-020-estimate-sales-1024m-beat-953m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.21...

 crude-oil-moves-lower-accenture-shares-tumble-after-q2-results

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow t...

 why-factset-research-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...

 gold-gains-1-micron-posts-upbeat-results

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow tra...

 apyx-medical-expects-fy2024-sales-of-497m-529m-versus-consensus-of-6018m-with-net-loss-of-265m-243m

Total revenue guidance assumes: Advanced Energy revenue in the range of $41.6 million to $44.6 million, representing a de...

 apyx-medical-q4-gaap-eps-028-may-not-be-comparable-to-018-estimate-sales-1466m-miss-1485m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.18...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION